title: [Bladder pain syndrome--an urological-gynecological problem].
abstract: Bladder Pain Syndrome remains a great challenge for urologists, both in diagnostics and treatment. Etiopathogenesis of the disease is unknown. It is reported that the reason for Bladder Pain Syndrome is the urothelium dysfunction resulting in the destruction of the protective glycosaminoglycan layer/barrier protecting the urothelium from bacteria adhesion and penetration of toxic substances/by bacteria. It is considered to be a syndrome of dysuria and diuresis. Urine analysis usually is normal. It is diagnosed after exclusion of other causes leading to painful symptoms. It is estimated that 90% of the cases of the disease concern women. Treatment with glycocorticosteroids, antihistaminic drugs and antiallergic drugs was not successful. The attempts to find the right method of treatment led to the introduction of hyaluronic acid, which alleviated Bladder Pain Syndrome and its symptoms. Hyaluronic acid reacting with glycosaminoglycans on the bladder decreases penetrability of irritant substances. The patients were treated with 4-8 weekly instillations--40 mg of hyaluronic acid in 50 ml NaCl solution for 1-2 months. After the last instillation, therapy is repeated for the next 6-8 months with one instillation monthly. This method is for patients a chance for getting rid of painful symptoms from the bladder
authors: Klinika Urologii Wojskowego Instytutu Medycznego Centralnego Szpitala Klinicznego MON, Warszawa, Polska. tom.uro@wp.pl
authors: Tomasz
authors: T
authors: Zabkowski
authors: Leszek
authors: L
authors: Bortnowski
authors: Henryk
authors: H
authors: Zieliński
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000283:Administration, Intravesical; D018856:Cystitis, Interstitial / Q000175:diagnosis* / Q000188:drug therapy* / Q000517:prevention & control; D004359:Drug Therapy, Combination; D005260:Female; D006176:Gynecology / Q000592:standards; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D010147:Pain Measurement; D011189:Potassium Chloride / Q000008:administration & dosage; D011788:Quality of Life; D012965:Sodium Chloride / Q000008:administration & dosage; D016896:Treatment Outcome; D001743:Urinary Bladder / Q000187:drug effects; D016387:Women's Health
chemical_list: D000276:Adjuvants, Immunologic; D012965:Sodium Chloride; D011189:Potassium Chloride; D006820:Hyaluronic Acid